Search results for "Highlights"


 
Results 11 - 20 of about 254 for "Highlights".

Early subspecialist involvement led to reduced infections among inpatients with diabetes

Researchers studied an early intervention model in which an inpatient diabetes team electronically identified patients with hyperglycemia and aimed to provide bedside management within 24 hours of admission, compared with a referral-based
April 2019

Insulin initiation in the hospital associated with death, ED visits, readmissions in older patients

not determine causality between insulin and mortality, we highlight a vulnerable population which needs additional resources in the discharge transition period,” the authors wrote.“ Further inquiry should determine appropriate interventions to
March 2019

SGLT2 inhibitors, GLP-1 receptor agonists compared for CV, renal outcomes

Sodium-glucose cotransporter-2 (SGLT2) inhibitors were associated with fewer hospitalizations for heart failure and slower progression of kidney disease while glucagon-like peptide-1 (GLP-1) receptor agonists were associated with lower risk of stroke
March 2019

Poor glycemic control associated with fracture in type 1 but not type 2 diabetes

Patients with type 1 diabetes and a mean three-year HbA1c level greater than 8.0% had a higher fracture risk than those with a mean three-year HbA1c level of 7.0% or less.
February 2019

3 actions may help reluctant patients begin insulin therapy for type 2 diabetes

Patients' perceived helpfulness of certain actions by health care professionals was linked to earlier insulin initiation and greater insulin continuation over time, a survey found.
February 2019

Drug-eluting stents may not confer advantage in diabetic patients

probably indicates a more accelerated intimal hyperplasia, greater degree of vascular inflammation and/or endothelial dysfunction, and increased plaque vulnerability in insulin-treated diabetic patients, and highlights the need for
January 2019

Cardiovascular event rates similar among newer second-line medications for type 2 diabetes

The comparison of dipeptidyl peptidase-4 inhibitors with other drug classes did find higher rates of major adverse cardiovascular events with basal insulin, sulfonylureas, and meglitinides than with the newer drugs.
January 2019

Insulin pump didn't improve glycemic control compared to training on injections

British patients with type 1 diabetes were enrolled in group training courses that taught flexible intensive insulin treatment and then randomized to an insulin pump or multiple daily injections and followed for two years.
April 2017

SGLT2 inhibitors associated with increased risk of amputations, diabetic ketoacidosis

Sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists had similar rates of other adverse events, including bone fracture, acute kidney injury, serious urinary tract infection, venous thromboembolism, and
December 2018

New equation with five variables helps predict hip fracture risk in type 2 diabetes

Age, sex, body mass index, peripheral sensory neuropathy, and estimated glomerular filtration rate were the included variables.
December 2018

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next